aTyr Pharma | LIFE - Current Assets


aTyr Pharma reported $58.36M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Ardelyx USD 381.87M 447K Mar/2026
aTyr Pharma USD 58.36M 9.21M Jun/2026
Biogen USD 7.58B 278.7M Sep/2026
Bristol-Myers Squibb USD 29.77B 1.19B Sep/2026
Cipla INR 250.61B 9.14B Sep/2026
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 137.28M 10.74M Mar/2026
CSL USD 11.85B 1000K Dec/2025
Curis USD 16.61M 9.7M Mar/2026
GlaxoSmithKline GBP 17.9B 336M Sep/2026
Grifols EUR 5.96B 316.31M Dec/2025
Lakefront Biotherapeutics EUR 2.31B 751.38M Jun/2026
Novartis USD 27.35B 744M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
United Therapeutics USD 3.48B 611.7M Jun/2026